【発明の名称】トリアジン抗ウイルス化合物

Title:

【発明の名称】トリアジン抗ウイルス化合物

Document Type and Number:

Japanese Patent JP2002509140

Kind Code:

A

Abstract:

The present invention provides pharmaceutical formulations comprising 1,3,5-triazine derivatives. The compounds and formulations of the present invention exhibit a range of activities, including antiviral and antibiotic activities, and the formulations may be used, alone or in combination, as a method of treating a patient in need of antiviral and/or antibiotic therapy. The triazine derivatives of the present invention bind to and inhibit functional nucleic acids, and hence, have broad applicability in the treatment of conditions associated with DNA and RNA viruses.

More Like This:

JP2004529088	Treatment of inflammatory and immune disorders with IkB kinase (IKK) inhibitors
JP5757495	Use of TNF inhibitors for the treatment of erosive polyarthritis
JP2013537036	Functional food composition and its production method

Inventors:

Arenas, James, Yi
Claude, Sharon, Tea
Fleming, Elizabeth, Es
Cyan, e, bin

Application Number:

JP2000540126A

Publication Date:

March 26, 2002

Filing Date:

January 13, 1999

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Anadies Pharmaceuticals, Inc.

International Classes:

A61K31/519; A61K31/53; A61K31/5377; A61K31/55; A61P1/16; A61P31/12; C07D251/66; C07D251/70; C07D401/12; C07D403/12; C07D405/12; C07D409/12; C07D487/04; (IPC1-7): C07D251/66; A61K31/519; A61K31/53; A61K31/5377; A61K31/55; A61P1/16; A61P31/12; C07D251/70; C07D401/12; C07D403/12; C07D405/12; C07D409/12; C07D487/04

Attorney, Agent or Firm:

Hajime Sakai (1 person outside)

Previous Patent: JP2002509139

Next Patent: 芳香族オレフィンおよび１−アリールピペラジンから１−アリール−４−�...